Clinical trial
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the…
NCT00489515 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00489515 |
|---|---|
| Title | Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder |
| Official title | Visceral Lymphatic Mapping Project: A Pilot Study |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Colorectal Cancer, Gallbladder Cancer, Gastric Cancer, Pancreatic Cancer, Small Intestine Cancer |
| Enrollment | 115 |
| Start date | Feb 1, 1999 |
| Primary completion | Jun 1, 2009 |
| Completion | Aug 1, 2010 |
| First posted | Jun 21, 2007 |
| Last update posted | May 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: